Evidence map›Paper›PMID 34598818›Full record

ArticleVaccine2021

Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.

Megan G Hofmeister, Mark K Weng, Douglas Thoroughman, Erica D Thomasson, Shannon McBee, Monique A Foster, Jim Collins, Cole Burkholder, Ryan J Augustine, Philip R Spradling

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Megan G HofmeisterDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: lxn7@cdc.gov.
Mark K WengDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Douglas ThoroughmanKentucky Department for Public Health, Frankfort, KY, United States; Career Epidemiology Field Officer Program, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Erica D ThomassonCareer Epidemiology Field Officer Program, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, GA, United States; Bureau for Public Health, West Virginia Department of Health and Human Resources, Charleston, WV, United States.
Shannon McBeeBureau for Public Health, West Virginia Department of Health and Human Resources, Charleston, WV, United States.
Monique A FosterDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Jim CollinsDivision of Communicable Diseases, Michigan Department of Health and Human Services, Lansing, MI, United States.
Cole BurkholderDivision of Communicable Diseases, Michigan Department of Health and Human Services, Lansing, MI, United States.
Ryan J AugustineDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Philip R SpradlingDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundSafe and effective hepatitis A vaccines have been recommended in the United States for at-risk adults since 1996; however, adult vaccination coverage is low.

methodsAmong a random sample of adult outbreak-associated hepatitis A cases from three states that were heavily affected by person-to-person hepatitis A outbreaks, we assessed the presence of documented Advisory Committee on Immunization Practices (ACIP) indications for hepatitis A vaccination, hepatitis A vaccination status, and whether cases that were epidemiologically linked to an outbreak-associated hepatitis A case had received postexposure prophylaxis (PEP).

resultsOverall, 74.1% of cases had a documented ACIP indication for hepatitis A vaccination. Fewer than 20% of epidemiologically linked cases received PEP.

conclusionsEfforts are needed to increase provider awareness of and adherence to ACIP childhood and adult hepatitis A vaccination and PEP recommendations in order to stop the current person-to-person hepatitis A outbreaks and prevent similar outbreaks in the future.

Indexed as

Hepatitis AAdultChildDisease OutbreaksHumansImmunizationPrevalenceUnited StatesVaccinationDisease outbreaksHepatitis AHepatitis A vaccinesPostexposure prophylaxisUnited States

Identifiers

PMID34598818
PMCPMC10962283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.